Table 2.
Demographic characteristics of participants who underwent genomic testing
| Characteristic | Retrospective cohort (2013–2019; n = 714) | Prospective cohort (2017–2022; n = 667) | All KidGen cohort (N = 1381) |
|---|---|---|---|
| Patient | |||
| Adult (≥18 yr) | 387 (54.20%) | 462 (69.27%) | 849 (61.48%) |
| Pediatric (<18 yr) | 327 (45.80%) | 205 (30.73%) | 532 (38.52%) |
| Total | 714 | 667 | 1381 |
| Median Age (IQR) | 22 (6–42) n = 707 (99%) | 33 (17–49) n = 594 (89%) | 29 (10–45) n = 1301 (94%) |
| Sexa | |||
| Male | 339 (47.48%) | 327 (49.02%) | 666 (48.23%) |
| Female | 374 (52.38%) | 289 (43.33%) | 663 (48.01%) |
| Unknown | 1 (0.14%) | 51 (7.65%) | 52 (3.76%) |
| Total | 714 | 667 | 1381 |
| Location | |||
| Queensland | 324 (45.38%) | 164 (24.59%) | 488 (35.34%) |
| New South Wales | 226 (31.65%) | 137 (20.54%) | 363 (26.29%) |
| Victoria | 121 (16.95%) | 244 (36.58%) | 365 (26.43%) |
| South Australia | 28 (3.92%) | 59 (8.85%) | 87 (6.30%) |
| Western Australia | 10 (1.40%) | 63 (9.45%) | 73 (5.29%) |
| Northern Territory | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Tasmania | 5 (0.70%) | 0 (0.00%) | 5 (0.36%) |
| Total | 714 | 667 | 1381 |
Nominal variables are numbers with percent (%), while continuous variables are median with interquartile range (IQR).
a
Sex has here been defined as a set of biological attributes associated with physical and physiological features.